Study Claims Ozempic Lowers Biological Age
Researchers reveal that GLP-1 medication Ozempic may reduce biological age, offering new hope in the fight against aging and related health issues.
GLP-1 medications have proven to be versatile, originally developed for diabetes, then for obesity and weight loss, and now for various other conditions.
A 32-week trial by TruDiagnostic suggests that Ozempic may reduce biologic age by over three years.
The positive impact on weight-management makes the drugs helpful in treating conditions associated or impacted by obesity.
Author's summary: Ozempic may reduce biological age.
More News
- Stubb recalled his first meeting with Tokayev and was pleased to see Finnish brands in Astana
- Cisco and G42 Deepen US-UAE Technology Partnership to Build Secure, End-to-End AI Infrastructure in the UAE
- Honkarakenne Brings Finnish Timber Construction Expertise to Kazakhstan – Two New Memoranda of Understanding Signed to Advance Sustainable Tourism and Ecological Solutions
- From Rocks to Revenue: Malawi’s Minerals at a Crossroads - Malawi Nyasa Times - News from Malawi about Malawi
- MLB: The Last 10 World Series MVPs
- DELLA-MATTIA: Caputo has right to personal opinion, social media page
- NHS unveils radical plan to cut waiting times | National Health Executive
- Milei, the two Caputos and the two anchors
- Giving States Waivers From Accountability Is a Dangerous Step Backward for Kids
- In Review: Big Ass Sword by Andreas Butzbach